Evaluation of Safety, Side Effects and How the Drug CHF6467 Administered Via Intranasal Route is Absorbed, Modified and Removed in Healthy Subjects
Clinical trial NCT07163182 · RECRUITING
Trial details
- NCT number
- NCT07163182
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-15
- Primary completion
- 2026-08-11
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.